ID   U-343MGa
AC   CVCL_4773
SY   U-343 MG-A; U-343-MG-A; U343-MG-A; U-343 MGa; U343 MGa; U343MGa; U343
DR   BTO; BTO:0003218
DR   CLO; CLO_0009459
DR   CLDB; cl4586
DR   BioGRID_ORCS_Cell_line; 350
DR   BioSample; SAMN10988401
DR   Cell_Model_Passport; SIDM01421
DR   CLS; 300365
DR   DepMap; ACH-000036
DR   PharmacoDB; U343_1631_2019
DR   Wikidata; Q54973569
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RX   PubMed=3497714;
RX   PubMed=10709103;
RX   PubMed=30894373;
RX   PubMed=31068700;
CC   Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
CC   Population: Caucasian.
CC   Omics: Deep exome analysis.
CC   Genome ancestry: African=1.11%; Native American=0%; East Asian, North=4.21%; East Asian, South=0%; South Asian=0%; European, North=72.65%; European, South=22.03% (PubMed=30894373).
CC   Derived from site: In situ; Brain, temporal lobe; UBERON=UBERON_0001871.
ST   Source(s): CLS
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 9,13
ST   D16S539: 9,12
ST   D18S51: 23
ST   D21S11: 31,33.2
ST   D3S1358: 15,17
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   D8S1179: 13,14
ST   FGA: 19,20
ST   Penta D: 9,10
ST   Penta E: 10,12
ST   TH01: 6,9.3
ST   TPOX: 8,9
ST   vWA: 17,18
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_S471 ! U-343MG
SX   Male
AG   54Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 30-01-24; Version: 24
//
RX   DOI=10.1016/B978-0-12-333530-2.50005-8;
RA   Nister M., Westermark B.;
RT   "Human glioma cell lines.";
RL   (In) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.17-42; Academic Press; New York (1994).
//
RX   PubMed=3497714;
RA   Nister M., Wedell B., Betsholtz C., Bywater M., Pettersson M.,
RA   Westermark B., Mark J.;
RT   "Evidence for progressional changes in the human malignant glioma line
RT   U-343 MGa: analysis of karyotype and expression of genes encoding the
RT   subunit chains of platelet-derived growth factor.";
RL   Cancer Res. 47:4953-4960(1987).
//
RX   PubMed=10709103; DOI=10.1002/(SICI)1097-0215(20000315)85:6<819::AID-IJC15>3.0.CO;2-Q;
RA   Enblad P., Hesselager G., Bongcam-Rudloff E., Hallin I.,
RA   Westermark B., Nister M.;
RT   "Modulation of phenotype and induction of irregular vessels accompany
RT   high tumorigenic potential of clonal human glioma cells xenografted to
RT   nude-rat brain.";
RL   Int. J. Cancer 85:819-828(2000).
//
RX   PubMed=30894373; DOI=10.1158/0008-5472.CAN-18-2747;
RA   Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.;
RT   "An interactive resource to probe genetic diversity and estimated
RT   ancestry in cancer cell lines.";
RL   Cancer Res. 79:1263-1273(2019).
//
RX   PubMed=31068700; DOI=10.1038/s41586-019-1186-3;
RA   Ghandi M., Huang F.W., Jane-Valbuena J., Kryukov G.V., Lo C.C.,
RA   McDonald E.R. III, Barretina J.G., Gelfand E.T., Bielski C.M., Li H.-X.,
RA   Hu K., Andreev-Drakhlin A.Y., Kim J., Hess J.M., Haas B.J., Aguet F.,
RA   Weir B.A., Rothberg M.V., Paolella B.R., Lawrence M.S., Akbani R.,
RA   Lu Y.-L., Tiv H.L., Gokhale P.C., de Weck A., Mansour A.A., Oh C.,
RA   Shih J., Hadi K., Rosen Y., Bistline J., Venkatesan K., Reddy A.,
RA   Sonkin D., Liu M., Lehar J., Korn J.M., Porter D.A., Jones M.D.,
RA   Golji J., Caponigro G., Taylor J.E., Dunning C.M., Creech A.L.,
RA   Warren A.C., McFarland J.M., Zamanighomi M., Kauffmann A.,
RA   Stransky N., Imielinski M., Maruvka Y.E., Cherniack A.D.,
RA   Tsherniak A., Vazquez F., Jaffe J.D., Lane A.A., Weinstock D.M.,
RA   Johannessen C.M., Morrissey M.P., Stegmeier F., Schlegel R.,
RA   Hahn W.C., Getz G., Mills G.B., Boehm J.S., Golub T.R., Garraway L.A.,
RA   Sellers W.R.;
RT   "Next-generation characterization of the Cancer Cell Line
RT   Encyclopedia.";
RL   Nature 569:503-508(2019).
//